team, innovation
Slide

Thought Leadership

Our experts share their analysis and points of view on issues happening within the market access space.

Latest Articles

broadeningaccess_featuredimage

Broadening Access to CAR-T Through the Community – What is Holding Us Back and What is Needed?

bispecificantibody_featuredimage

How Bispecific Antibody Therapies are Impacting Community Practices, and Three Trends to Watch

biopharmaforecasting_featuredimage

Overcoming Five Major Challenges in Biopharma Forecasting

globalmarketaccess_featuredimage

Why U.S. Market Access Strategies Do Not Translate in Ex-U.S. Markets

oncologyclinicalpathways_featuredimage

The Evolving Role of Oncology Clinical Pathways in Value-Based Care

A conveyor belt at a pharmaceutical factory is filled with bottles of pills

Provider Rebate Aggregators: Implications for Manufacturers

broadeningaccess_featuredimage

Broadening Access to CAR-T Through the Community – What is Holding Us Back and What is Needed?

bispecificantibody_featuredimage

How Bispecific Antibody Therapies are Impacting Community Practices, and Three Trends to Watch

biopharmaforecasting_featuredimage

Overcoming Five Major Challenges in Biopharma Forecasting

globalmarketaccess_featuredimage

Why U.S. Market Access Strategies Do Not Translate in Ex-U.S. Markets

oncologyclinicalpathways_featuredimage

The Evolving Role of Oncology Clinical Pathways in Value-Based Care

A conveyor belt at a pharmaceutical factory is filled with bottles of pills

Provider Rebate Aggregators: Implications for Manufacturers